In concordance with clinical data, the CRC cell line showed the lowest FGF2 expression, while three NPC cell lines, 5–8F, CNE-1, and HONE-1, expressed dramatically high levels of FGF2 (Fig. 3A). This evidence concerns the gene FGF2 and colorectal carcinoma.